AOD-9604 Dosage Guide: Reconstitution, Injection Volumes, and Fat Loss Protocol

AOD-9604 (Anti-Obesity Drug 9604) is a modified GH fragment (176-191) studied for its lipolytic properties and fat metabolism effects. Unlike GH itself, AOD-9604 does not significantly affect blood glucose or IGF-1. This guide covers practical reconstitution and dosing.

What Vials Typically Come In

AOD-9604 research vials are commonly available as:

• 5 mg vials (most standard)
• 2 mg vials
• 10 mg vials

How to Reconstitute AOD-9604

Standard reconstitution for a 5 mg vial:

1. Swab the stopper with alcohol; allow to dry

2. Draw 1–2 mL bacteriostatic water

3. Inject water slowly down the vial wall

4. Swirl gently — do not shake

5. Allow 2 minutes for complete dissolution

Concentration examples:

• 5 mg + 1 mL BW → 5000 mcg/mL
• 5 mg + 2 mL BW → 2500 mcg/mL
• 2 mg + 1 mL BW → 2000 mcg/mL

Standard Research Dosage Ranges

The most commonly referenced dose from clinical research is 300–500 mcg/day, administered subcutaneously in a fasted state.

Injection Volume Table

Using a 5000 mcg/mL solution (5 mg in 1 mL BW):

Using a 2500 mcg/mL solution (5 mg in 2 mL BW):

Use the Dose Calculator to calculate exact volumes for any concentration.

Frequency, Timing, and Cycle Length

• Timing: Fasted state is critical — administer 30–60 minutes before first meal (morning injection on an empty stomach)
• Frequency: Once daily
• Cycle length: 8–12 weeks; some research extends to 20 weeks
• Injection site: Subcutaneous to abdomen is most common; closer to fat deposits that are targeted

Storage

• Lyophilised vials: -20°C for long-term; 2–8°C short-term
• After reconstitution: 2–8°C; use within 28 days